Research and Development Centre for Innovative Medicines Selvita S.A.

<p><strong>Research and Development Centre for Innovative Medicines Selvita S.A.</strong></p>
Typology
Office and lab building
Location
Cracow
Investor
Selvita S.A. / Ryvu Therapeutics
Building area
8300 m2
Date of creation
2017-2019

Multi-discipline project: concept with technology design, construction and executive design for the investment task entitled..: “Construction of the Research and Development Centre of Innovative Medicines Selvita S.A.” in Kraków.

 

The investor assumes the implementation of the investment divided into three stages. As part of the first stage, the construction of a laboratory building with an area of 8 300m2 was completed, containing biological laboratories, a significant part of which, over 3 000 m2, will be BSL 2 class 2 biosafety laboratories. There is also an animal house for mice kept in the SPF standard. The laboratory is characterized by a higher standard of safety, including image and acoustic monitoring of laboratory work, decontamination systems at the exit of the chamber and two-stage air filtration and emergency power supply system.

Expand content

Reach out.

Contact us! Describe your case in detail and we will respond as quickly as possible.

    EnglishPoland